Key result
Thirty-day readmission after acute ischemic stroke is linked to ~76% higher cumulative hospitalization costs.
Why the study?
This study aimed to empirically investigate the risk factors, timing, and cost of 30-day readmission after ischemic stroke.
Cohort
In a Chinese cohort, 30-day readmission after acute ischemic stroke occurred in 18.8% of patients, significantly increasing hospitalization costs and highlighting the need for targeted interventions.
Answers are grounded in this paper and cite their sources.
Readmission after ischemic stroke drives higher costs; leaves open whether targeted interventions can mitigate this burden.
BACKGROUND: This study aims to empirically investigated the risk factors, timing, and cost of the 30-day readmission after ischemic stroke. METHODS: test was used in univariate analysis. A multivariate cox model and a multivariate linear regression method were used to identify those predictors of the 30-day readmission and the cumulative cost, respectively. RESULTS: The overall 30-day readmission rate was 18.8%, of which 36.4% and 60.9% were readmitted within 7 and 14 days, respectively. Nearly 50% were readmitted for recurrent ischemic stroke. Male, rural areas, aged under 50, resident's insurance scheme, primary hospitals, LOS under 1 week or over two weeks, and comorbidities including congestive heart failure, solid tumor, fluid and electrolyte disorders, and depression were independent predictors of 30-day readmission. We also found that the 30-day readmission was associated with an 76% increase in the cumulative hospitalization cost (P < 0.001) after multivariate adjustment analysis. CONCLUSIONS: The findings highlight the importance of the readmission of ischemic stroke and corresponding policies and interventions, and our work could provide a potential manage path for the reduction of readmission rate.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) conducted a cohort in Acute ischemic stroke. Thirty-day readmission after acute ischemic stroke occurred in 18.8% of patients and was associated with a 76% increase in cumulative hospitalization cost.
Synapse has enriched 10 related papers. Consider them for comparative context: